A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases

A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases

ABSTRACT Immunosuppression is an important risk factor for leishmaniasis. We assessed the clinical profile, geographic distribution and prevalence of leishmaniasis in patients undergoing immunosuppressive therapy for dermatological, rheumatological or gastroenterological autoimmune diseases. We iden...

Full description

Bibliographic Details
Main Authors:	Patrícia Shu Kurizky, Fernanda Ferraço Marianelli, Mariana Vicente Cesetti, Giovanni Damiani, Raimunda Nonata Ribeiro Sampaio, Lais Mitsue Tanaka Gonçalves, Carlos Augusto Felipe de Sousa, Sofia Sales Martins, Sebastian Vernal, Licia Maria Henrique da Mota, Ciro Martins Gomes
Format:	Article
Language:	English
Published:	Universidade de São Paulo
Series:	Revista do Instituto de Medicina Tropical de São Paulo
Subjects:	immunosuppression leishmaniasis systematic review treatment
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652020000100217&lng=en&tlng=en

Similar Items

Appropriate Screening for Leishmaniasis before Immunosuppressive Treatments
by: Antonio Cascio, et al.
Published: (2009-10-01)

Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy
by: Gilles Darcis, et al.
Published: (2017-07-01)

Immunity and immunosuppression in experimental visceral leishmaniasis
by: Goto H., et al.
Published: (2004-01-01)

Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis
by: Daniel Holanda Barroso, et al.
Published: (2021-04-01)

Unusual clinical presentation of cutaneous leishmaniasis in a patient with corticosteroid‐induced immunosuppression
by: Maryam Mahdavi, et al.
Published: (2021-01-01)

Visceral Dissemination of Mucocutaneous Leishmaniasis in a Kidney Transplant Recipient
by: Nídia Marques, et al.
Published: (2021-12-01)

Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients
by: Thomas Schwartz, et al.
Published: (2019-08-01)

Dermatologic and otorhinolaryngologic manifestations in leishmaniasis
by: Mota, Luiz Alberto Alves, et al.
Published: (2011-07-01)

American cutaneous leishmaniasis triggered byelectrocoagulation
by: Sofia Sales Martins, et al.

Clinico-immunological spectrum of American tegumentary leishmaniasis and leprosy coinfection: A case series in Southeastern Brazil
by: Sebastian Vernal, et al.
Published: (2019-04-01)

Studies on a soluble immunosuppressive factor produced by Leishmania donovani infected macrophages
by: Fielding, Mark
Published: (1994)

Cell-mediated immune response to Leishmania chagasi experimental infection of BALB/c immunosuppressed mice
by: JG Machado, et al.
Published: (2010-01-01)

Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity
by: John M. Curtin, et al.
Published: (2021-03-01)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
by: Sofia Sales Martins, et al.
Published: (2021-07-01)

Recurrent cutaneous leishmaniasis Leishmaniose recidiva cútis
by: Ciro Martins Gomes, et al.
Published: (2013-06-01)

The contribution of immune evasive mechanisms to parasite persistence in Visceral Leishmaniasis
by: Elisangela Oliveira De Freitas, et al.
Published: (2016-04-01)

Immunoactivation and immunopathogeny during active visceral leishmaniasis Imunoativação e imunopatogenia durante leishmaniose visceral ativa
by: Hiro Goto, et al.
Published: (2009-10-01)

Visceral leishmaniasis in a patient with ulcerative colitis: A case report
by: Janković Goran, et al.
Published: (2020-01-01)

Tratamento da Leishmaniose Tegumentar Americana Treatment of american cutaneous leishmaniasis
by: Edson Borges de Lima, et al.
Published: (2007-04-01)

Dynamics of immunosuppression in hamsters with experimental visceral leishmaniasis
by: C. Fazzani, et al.
Published: (2011-07-01)

Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis
by: Ciro Martins Gomes, et al.
Published: (2015-04-01)

Disseminated Leishmaniasis Due to Using Immunosuppression Drugs: A Case Report
by: Maryam AFSHOON, et al.
Published: (2020-06-01)

Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series
by: Rachel A. Brown, et al.
Published: (2021-06-01)

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis
by: Bruna Côrtes Rodrigues, et al.
Published: (2020-12-01)

American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy
by: TANG Shanhong
Published: (2015-04-01)

A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2019-03-01)

Immunosuppressants: implications in Orthodontics
by: Rogério Lacerda dos Santos, et al.
Published: (2012-04-01)

An atypical Toxoplasma gondii genotype in a rural Brazilian dog co-infected with Leishmania (Viannia) braziliensis
by: Rodrigo Costa da Silva, et al.
Published: (2015-04-01)

Lesões orais secundárias à leishmaniose visceral em um cão com hiperadrenocorticismo endógeno: relato de caso
by: M.S. Bochnakian, et al.

New World Leishmaniasis: The Role of Confocal Microscopy in Diagnosis and Follow-up - Tropical Dermatology
by: Ana Ortins-Pina, et al.
Published: (2018-12-01)

Impact of leishmaniasis on public health
by: L. B Camargo, et al.
Published: (2006-01-01)

Update in the treatment of cutaneous leishmaniasis
by: Sahar H Al-Natour
Published: (2009-01-01)

Immunochemotherapy in experimental leishmaniasis
by: Eslami, Zohreh.
Published: (1996)

Vaccines for canine leishmaniasis
by: Clarisa B. Palatnik-De-Sousa
Published: (2012-04-01)

Cutaneous leishmaniasis: diagnostic pitfall. Case report
by: Asmae EL Hatimi, et al.
Published: (2014-01-01)

Leishmaniasis cutánea en España Cutaneous leishmaniasis in Spain
by: F Pulgar, et al.
Published: (2011-09-01)

Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl/6 mice
by: Ana Angélica Amorim Santarem, et al.
Published: (2014-07-01)

Lupoid Cutaneous Leishmaniasis: Review
by: Maryam Amin Moghadam, et al.
Published: (2016-07-01)

Herbal Medicines for Immunosuppression
by: Zahra Amirghofran
Published: (2012-06-01)

O uso da associação azitromicina e N-metil glucamina no tratamento da leishmaniose cutânea causada por Leishmania (Leishmania) amazonensis em camundongos C57BL6 The use of azythromycin and N-methyl glucamine for the treatment of cutaneous Leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL6 mice
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2009-04-01)

Cannot write session to /tmp/vufind_sessions/sess_bc30j7ehu2jni6fk5f8fsjdl9q